Collegium Pharmaceutical (COLL)
(Delayed Data from NSDQ)
$31.88 USD
-0.69 (-2.12%)
Updated Jun 12, 2024 04:00 PM ET
After-Market: $31.86 -0.02 (-0.06%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum A VGM
Brokerage Reports
0 items in cart
Collegium Pharmaceutical, Inc. [COLL]
Reports for Purchase
Showing records 21 - 40 ( 91 total )
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
1Q21: Beat on Nucynta; Near-Term Xtampza Economics Trade for Long-Term Market Share and Leverage is Fine
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
4Q20; Xtampza ER Volume Acceleration Bodes Well for 2021; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Biotech Should Keep the Wind at its Back in 2021; Top Healthcare Picks
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Solid 2021 Guidance Eases Street Growth Concerns; Operating Leverage Undervalued
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
3Q20: Expect Another Leg up in 2021; Early-January Guidance; Lower to $29 on Moderated Estimates, But Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
2Q20: Sequential Rx and Sales Growth Despite COVID Headwind; Stock Remarkably Cheap; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O